HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shot up 0.6% during trading on Thursday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6 %
The company’s fifty day simple moving average is $25.31 and its 200 day simple moving average is $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Recommended Stories
- Five stocks we like better than HemaCare
- What is the Australian Securities Exchange (ASX)
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Health Care Stocks Explained: Why You Might Want to Invest
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Stock Sentiment Analysis: How it Works
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
